Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.47
BATS BZX Real-Time Price
As of 12:50pm ET
 -0.09 / -3.52%
Today’s Change
0.33
Today|||52-Week Range
5.75
+517.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues752.3K735.5K729.1K2.6M
 
 
 
 
 
Cost of Goods Sold48.2K45.4K23.0K37.5K
 
 
 
 
 
Depreciation And Amortization1.5K1.9K1.7K1.8K
 
 
 
 
 
 
Operating ExpensesGross Income702.5K688.2K704.4K2.5M
 
 
 
 
 
General Expenses1.6M1.4M1.4M915.6K
 
 
 
 
 
Research And Development1.1M897.5K737.3K557.5K
 
 
 
 
 
Total Operating Expenses1.6M1.5M1.4M954.9K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-860.7K-734.3K-710.9K1.6M
 
 
 
 
 
Extraordinary Credit0.000.00189.6K0.00
 
 
Interest Expense On Debt--0.0070.7K52.5K
 
 
 
Other Expenses-44.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-904.7K-725.0K-592.0K1.6M
 
 
 
 
 
Income Taxes-84.4K-36.8K-99.2K0.00
 
 
 
 
Net Income-820.3K-688.2K-492.8K1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.1M35.4M35.9M36.3M
 
 
 
 
 
Shares To Calculate EPS Diluted35.1M35.4M35.9M38.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.02-$0.02-$0.02$0.04
 
 
 
 
 
EPS Diluted-$0.02-$0.02-$0.01$0.04